Utilizing human stem cells to grasp and deal with diabetes
Air date: Thursday, December 15, 2016, 3:00:00 PM
Class: WALS – Wednesday Afternoon Lectures
Description: NIH Director’s Wednesday Afternoon Lecture Sequence
One aim of regenerative medication is to interchange lacking or dysfunctional cells in sufferers. The Melton lab has pursued this aim for diabetics, specializing in the potential for turning human stem cells into useful pancreatic beta cells, the cells that sense glucose and supply simply the correct quantity of insulin. Folks with both Kind 1 (juvenile) or Kind 2 diabetes may benefit from the provision of a vast provide of useful beta cells. On this lecture, Dr. Melton will talk about the challenges of and progress in producing useful beta cells and level to the way in which ahead on transplanting these cells into sufferers.
For extra data go to https://oir.nih.gov/wals
Writer: Douglas A. Melton, Ph.D., Xander College Professor at Harvard College; Co-Director of the Harvard Stem Cell Institute; Investigator, Howard Hughes Medical Institute
Everlasting hyperlink: https://videocast.nih.gov/launch.asp?21062